Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

GPR68 Inhibitors

GPR68 inhibitors form a chemical class of compounds that and reversibly target GPR68, also known as OGR1 (Ovarian Cancer G-protein coupled Receptor 1). GPR68 is a proton-sensing G-protein-coupled receptor involved in various physiological processes, including pH sensing, cell migration, and immune response modulation. These inhibitors are specifically engineered to interact with GPR68, aiming to disrupt its signaling and modulate cellular responses associated with its activation. The chemical structure of GPR68 inhibitors enables them to bind to specific regions or binding sites on the receptor, potentially interfering with its ability to sense protons or engage downstream signaling partners. Researchers employ GPR68 inhibitors in biochemical and cellular studies to unravel the intricacies of GPR68's role in cellular processes and its potential implications in diverse biological contexts. The design and development of these inhibitors rely on a comprehensive understanding of GPR68's structural features and its involvement in pH sensing and signaling pathways, providing valuable tools for advancing research in the field of cellular communication and response regulation.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Riluzole

1744-22-5sc-201081
sc-201081A
sc-201081B
sc-201081C
20 mg
100 mg
1 g
25 g
$20.00
$193.00
$213.00
$317.00
1
(1)

Riluzole is a drug that has been reported to inhibit GPR68.

ZD 7288

133059-99-1sc-361419
sc-361419A
10 mg
50 mg
$211.00
$552.00
(1)

ZD7288 is a selective blocker of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels that has also been reported to inhibit GPR68.